An Efficacy and Safety Study of 24 Week Treatment With Mavodelpar (REN001) in Primary Mitochondrial Myopathy Patients
Clinical trial NCT04535609 · COMPLETED
Trial details
- NCT number
- NCT04535609
- Sponsor
- Reneo Pharma Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-21
- Primary completion
- 2023-09-12
- Enrollment
- 213
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.